The Canadian Press on MSN

B.C. Human Rights Commissioner says stigmatizing drug use is a violation

British Columbia's rights watchdog has criticized the province for stigmatizing people who use drugs, calling it a violation ...

Drug User Liberation Front founders found guilty of drug trafficking

A B.C. Supreme Court judge ruled Friday that Jeremy Kalicum and Eris Nyx had broken the law by selling the drugs to their members, and were each guilty of three counts of possession for the purpose of ...

FIRST READING: B.C. human rights chief declares that it's colonialist to stigmatize drug use

Overdose crisis is 'rooted in colonial approaches that prioritize individualism over community, wealth over health and power ...

BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics

Collaboration uses Receptor AI's platform to design highly selective anti-cancer kinase inhibitor products for BriaPro, a ...
The Vancouver Sun on MSN

'It's progress:' Lawsuit settlement includes B.C. government commitments on future overdose prevention sites

As part of the settlement, which was finalized in September, Vancouver Coastal Health has committed to following the Ministry ...

Clearmind Medicine Accelerate FDA-Approved Alcohol Use Disorder Clinical Trial by Activating Fifth Elite Global Medical Site

Prestigious Hadassah Medical Center Joins Yale, Johns Hopkins, Tel Aviv Sourasky and IMCA, in Evaluating the Company’s proprietary non-hallucinogenic MEAI-based oral drug candidate Vancouver, Canada, ...

AbCellera Biologics Inc. (ABCL) Presents at Jefferies London Healthcare Conference 2025 Transcript

Jefferies London Healthcare Conference 2025 November 20, 2025 8:00 AM EST Great. Hello. Good afternoon, everyone. Welcome to the final day of the Jefferies London Healthcare Conference. It is now my ...

Clearmind Medicine Announces Positive Top-Line Results from First Cohort of its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder

The top-line data from the first cohort demonstrate a favorable safety profile, with no serious adverse events reported and the treatment generally well-tolerated across all participants. Additionally ...

Clearmind Medicine Receives Final Approval to Expand its FDA Regulated Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to ...

Absci Corporation (ABSI) Presents at Jefferies London Healthcare Conference 2025 Transcript

Jefferies London Healthcare Conference 2025 November 18, 2025 4:30 AM ESTCompany ParticipantsSean McClain - Founder, CEO, ...